Literature DB >> 28578164

Discriminative ability of commonly used indices to predict adverse outcomes after poster lumbar fusion: a comparison of demographics, ASA, the modified Charlson Comorbidity Index, and the modified Frailty Index.

Nathaniel T Ondeck1, Daniel D Bohl2, Patawut Bovonratwet1, Ryan P McLynn1, Jonathan J Cui1, Blake N Shultz1, Adam M Lukasiewicz1, Jonathan N Grauer3.   

Abstract

BACKGROUND CONTEXT: As research tools, the American Society of Anesthesiologists (ASA) physical status classification system, the modified Charlson Comorbidity Index (mCCI), and the modified Frailty Index (mFI) have been associated with complications following spine procedures. However, with respect to clinical use for various adverse outcomes, no known study has compared the predictive performance of these indices specifically following posterior lumbar fusion (PLF).
PURPOSE: This study aimed to compare the discriminative ability of ASA, mCCI, and mFI, as well as demographic factors including age, body mass index, and gender for perioperative adverse outcomes following PLF. STUDY DESIGN/
SETTING: A retrospective review of prospectively collected data was performed. PATIENT SAMPLE: Patients undergoing elective PLF with or without interbody fusion were extracted from the 2011-2014 American College of Surgeons National Surgical Quality Improvement Program (NSQIP). OUTCOME MEASURES: Perioperative adverse outcome variables assessed included the occurrence of minor adverse events, severe adverse events, infectious adverse events, any adverse event, extended length of hospital stay, and discharge to higher-level care.
METHODS: Patient comorbidity indices and characteristics were delineated and assessed for discriminative ability in predicting perioperative adverse outcomes using an area under the curve analysis from the receiver operating characteristics curves.
RESULTS: In total, 16,495 patients were identified who met the inclusion criteria. The most predictive comorbidity index was ASA and demographic factor was age. Of these two factors, age had the larger discriminative ability for three out of the six adverse outcomes and ASA was the most predictive for one out of six adverse outcomes. A combination of the most predictive demographic factor and comorbidity index resulted in improvements in discriminative ability over the individual components for five of the six outcome variables.
CONCLUSION: For PLF, easily obtained patient ASA and age have overall similar or better discriminative abilities for perioperative adverse outcomes than numerically tabulated indices that have multiple inputs and are harder to implement in clinical practice.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ASA; Adverse events; Charlson Comorbidity Index; Discriminative ability; Frailty Index; Posterior lumbar fusion

Mesh:

Year:  2017        PMID: 28578164     DOI: 10.1016/j.spinee.2017.05.028

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  23 in total

1.  What Is the Adverse Event Profile After Prophylactic Treatment of Femoral Shaft or Distal Femur Metastases?

Authors:  Ryan P McLynn; Nathaniel T Ondeck; Jonathan N Grauer; Dieter M Lindskog
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

2.  Association of preoperative medication with postoperative length of stay in elderly patients undergoing hip fracture surgery.

Authors:  Jianghua Shen; Yahui Yu; Chaodong Wang; Yanqi Chu; Suying Yan
Journal:  Aging Clin Exp Res       Date:  2020-05-21       Impact factor: 3.636

3.  The immense heterogeneity of frailty in neurosurgery: a systematic literature review.

Authors:  Julia Pazniokas; Chirag Gandhi; Brianna Theriault; Meic Schmidt; Chad Cole; Fawaz Al-Mufti; Justin Santarelli; Christian A Bowers
Journal:  Neurosurg Rev       Date:  2020-01-17       Impact factor: 3.042

4.  How Common-and How Serious- Is Clostridium difficile Colitis After Geriatric Hip Fracture? Findings from the NSQIP Dataset.

Authors:  Patawut Bovonratwet; Daniel D Bohl; Glenn S Russo; Nathaniel T Ondeck; Denis Nam; Craig J Della Valle; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

5.  What Associations Exist Between Comorbidity Indices and Postoperative Adverse Events After Total Shoulder Arthroplasty?

Authors:  Michael C Fu; Nathaniel T Ondeck; Benedict U Nwachukwu; Grant H Garcia; Lawrence V Gulotta; Nikhil N Verma; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

6.  Hospital outcomes of scoliosis surgery in children with Prader-Willi Syndrome: comparison with adolescent idiopathic scoliosis.

Authors:  Kade S McQuivey; Joseph R Sheridan; Andrew Chung; Cory Mayfield; Matthew Gulbrandsen; Joseph C Brinkman; Mohan V Belthur
Journal:  Spine Deform       Date:  2021-05-05

7.  Preoperative opiate use leads to increased postoperative opiate use and readmissions after anterior cervical discectomy and fusion.

Authors:  Jun Ho Chung; Alex Mierke; Omar Ramos; Whitney Kagabo; Warren Boling; Wayne Cheng; Olumide Danisa
Journal:  J Spine Surg       Date:  2022-06

8.  Trajectory of health-related quality of life and its determinants in patients who underwent lumbar spine surgery: a 1-year longitudinal study.

Authors:  En-Yuan Lin; Pin-Yuan Chen; Pei-Shan Tsai; Wen-Cheng Lo; Hsiao-Yean Chiu
Journal:  Qual Life Res       Date:  2018-06-02       Impact factor: 4.147

9.  Are Lipped Polyethylene Liners Associated with Increased Revision Rates in Patients with Uncemented Acetabular Components? An Observational Cohort Study.

Authors:  Michael C Wyatt; Michael R Whitehouse; David C Kieser; Chris M A Frampton; Gary J Hooper
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

10.  Frailty Assessment and Prehabilitation Before Complex Spine Surgery in Patients With Degenerative Spine Disease: A Narrative Review.

Authors:  Basma Mohamed; Ramani Ramachandran; Ferenc Rabai; Catherine C Price; Adam Polifka; Daniel Hoh; Christoph N Seubert
Journal:  J Neurosurg Anesthesiol       Date:  2021-08-05       Impact factor: 3.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.